Cargando…
Rituximab experience from a single centre for patients with rheumatoid arthritis-related interstitial lung disease
OBJECTIVE. To demonstrate the effects of rituximab (RTX) in patients with rheumatoid arthritis-related interstitial lung disease (RA-ILD). METHODS. A total of 165 patients who used RTX for the management of rheumatoid arthritis were retrospectively scrutinised. Among these, 26 patients diagnosed wit...
Autores principales: | Sahin Eroglu, Didem, Colaklar, Anil, Baysal, Serdar, Torgutalp, Murat, Baygul, Asaf, Yayla, Mucteba Enes, Sezer, Serdar, Uzun, Caglar, Ozdemir Kumbasar, Ozlem, Turgay, Tahsin Murat, Kinikli, Gulay, Ates, Askin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766850/ https://www.ncbi.nlm.nih.gov/pubmed/36791029 http://dx.doi.org/10.36141/svdld.v39i3.12337 |
Ejemplares similares
-
Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels
por: Torgutalp, Murat, et al.
Publicado: (2021) -
The factors predicting development of serious infections in ANCA-associated vasculitis
por: Uslu Yurteri, Emine, et al.
Publicado: (2023) -
Causes of severe infections in patients with systemic sclerosis and associated factors
por: YAYLA, Müçteba Enes, et al.
Publicado: (2022) -
Indications and risk factors for hospitalization in patients with primary Sjögren syndrome: experience from a tertiary center in Turkey
por: Yayla, Müçteba Enes, et al.
Publicado: (2022) -
High mobility group box- 1 levels may be associated with disease activity of Behcet’s disease
por: DÖNMEZ GÜLER, Dilara, et al.
Publicado: (2021)